IL128825A - Pressure gauge system for measuring intraocular pressure by flattening and / or a notch - Google Patents

Pressure gauge system for measuring intraocular pressure by flattening and / or a notch

Info

Publication number: IL128825A
Authority: IL; Israel
Prior art keywords: contact device; eye; cornea; pressure; contact
Prior art date: 1996-09-04

Application number

IL12882597A

Other languages

English (en)

Hebrew (he)

Other versions

IL128825A0 (en

Original Assignee

Marcio Marc Aurelio Martins Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-04

Filing date

1997-09-04

Publication date

2004-07-25

1997-09-04 Application filed by Marcio Marc Aurelio Martins Ab filed Critical Marcio Marc Aurelio Martins Ab

1998-11-02 Priority claimed from US09/184,127 external-priority patent/US6120460A/en

2000-01-31 Publication of IL128825A0 publication Critical patent/IL128825A0/xx

2004-07-25 Publication of IL128825A publication Critical patent/IL128825A/en

Links

230000004410 intraocular pressure Effects 0.000 title claims abstract description 245
238000007373 indentation Methods 0.000 title description 115
210000004087 cornea Anatomy 0.000 claims abstract description 251
210000000744 eyelid Anatomy 0.000 claims abstract description 108
239000012530 fluid Substances 0.000 claims description 100
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 92
239000008103 glucose Substances 0.000 claims description 92
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 58
239000001301 oxygen Substances 0.000 claims description 58
229910052760 oxygen Inorganic materials 0.000 claims description 58
239000000126 substance Substances 0.000 claims description 48
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 44
239000003814 drug Substances 0.000 claims description 18
229940079593 drug Drugs 0.000 claims description 17
230000009471 action Effects 0.000 claims description 16
230000004913 activation Effects 0.000 claims description 12
230000035945 sensitivity Effects 0.000 claims description 10
206010041349 Somnolence Diseases 0.000 claims description 8
238000003860 storage Methods 0.000 claims description 8
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
239000011734 sodium Substances 0.000 claims description 5
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
239000011591 potassium Substances 0.000 claims description 4
229910052700 potassium Inorganic materials 0.000 claims description 4
229910052708 sodium Inorganic materials 0.000 claims description 4
230000007704 transition Effects 0.000 claims 1
210000001508 eye Anatomy 0.000 description 379
238000000034 method Methods 0.000 description 152
238000005259 measurement Methods 0.000 description 135
239000012528 membrane Substances 0.000 description 104
210000004379 membrane Anatomy 0.000 description 102
230000003287 optical effect Effects 0.000 description 97
230000005291 magnetic effect Effects 0.000 description 78
238000001514 detection method Methods 0.000 description 72
230000005540 biological transmission Effects 0.000 description 63
230000001965 increasing effect Effects 0.000 description 59
230000033001 locomotion Effects 0.000 description 56
210000004369 blood Anatomy 0.000 description 54
239000008280 blood Substances 0.000 description 54
230000008859 change Effects 0.000 description 44
230000007246 mechanism Effects 0.000 description 37
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 35
210000001519 tissue Anatomy 0.000 description 33
239000000306 component Substances 0.000 description 32
238000006073 displacement reaction Methods 0.000 description 31
239000000463 material Substances 0.000 description 30
210000000795 conjunctiva Anatomy 0.000 description 28
230000006870 function Effects 0.000 description 26
230000004044 response Effects 0.000 description 26
238000004458 analytical method Methods 0.000 description 25
208000010412 Glaucoma Diseases 0.000 description 24
230000007423 decrease Effects 0.000 description 24
238000001914 filtration Methods 0.000 description 24
230000000694 effects Effects 0.000 description 23
230000017531 blood circulation Effects 0.000 description 22
238000006243 chemical reaction Methods 0.000 description 22
210000001742 aqueous humor Anatomy 0.000 description 21
238000004364 calculation method Methods 0.000 description 21
238000012545 processing Methods 0.000 description 21
235000012000 cholesterol Nutrition 0.000 description 20
102000004190 Enzymes Human genes 0.000 description 19
108090000790 Enzymes Proteins 0.000 description 19
229940088598 enzyme Drugs 0.000 description 19
210000003786 sclera Anatomy 0.000 description 19
239000007789 gas Substances 0.000 description 18
210000004556 brain Anatomy 0.000 description 16
238000011156 evaluation Methods 0.000 description 16
239000011521 glass Substances 0.000 description 15
238000012544 monitoring process Methods 0.000 description 15
230000000541 pulsatile effect Effects 0.000 description 15
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 14
230000004397 blinking Effects 0.000 description 14
150000001875 compounds Chemical class 0.000 description 14
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
235000019420 glucose oxidase Nutrition 0.000 description 14
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 14
108010015776 Glucose oxidase Proteins 0.000 description 13
230000002829 reductive effect Effects 0.000 description 13
239000012503 blood component Substances 0.000 description 12
230000006378 damage Effects 0.000 description 12
230000003247 decreasing effect Effects 0.000 description 12
230000004386 ocular blood flow Effects 0.000 description 12
230000002093 peripheral effect Effects 0.000 description 12
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 12
230000009467 reduction Effects 0.000 description 12
230000000638 stimulation Effects 0.000 description 12
239000000758 substrate Substances 0.000 description 12
238000012800 visualization Methods 0.000 description 12
239000004366 Glucose oxidase Substances 0.000 description 11
229940116332 glucose oxidase Drugs 0.000 description 11
238000005286 illumination Methods 0.000 description 11
238000012360 testing method Methods 0.000 description 11
230000000007 visual effect Effects 0.000 description 11
210000004204 blood vessel Anatomy 0.000 description 10
238000012937 correction Methods 0.000 description 10
238000009792 diffusion process Methods 0.000 description 10
238000010438 heat treatment Methods 0.000 description 10
210000003205 muscle Anatomy 0.000 description 10
238000013021 overheating Methods 0.000 description 10
230000010349 pulsation Effects 0.000 description 10
230000008054 signal transmission Effects 0.000 description 10
201000010099 disease Diseases 0.000 description 9
238000002513 implantation Methods 0.000 description 9
239000000523 sample Substances 0.000 description 9
230000005236 sound signal Effects 0.000 description 9
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 8
238000013461 design Methods 0.000 description 8
210000004561 lacrimal apparatus Anatomy 0.000 description 8
238000004519 manufacturing process Methods 0.000 description 8
210000001328 optic nerve Anatomy 0.000 description 8
210000001525 retina Anatomy 0.000 description 8
210000003462 vein Anatomy 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
102000004877 Insulin Human genes 0.000 description 7
108090001061 Insulin Proteins 0.000 description 7
206010028980 Neoplasm Diseases 0.000 description 7
208000032140 Sleepiness Diseases 0.000 description 7
230000008901 benefit Effects 0.000 description 7
238000004891 communication Methods 0.000 description 7
210000003717 douglas' pouch Anatomy 0.000 description 7
239000003792 electrolyte Substances 0.000 description 7
238000005516 engineering process Methods 0.000 description 7
230000000004 hemodynamic effect Effects 0.000 description 7
229940125396 insulin Drugs 0.000 description 7
230000003647 oxidation Effects 0.000 description 7
238000007254 oxidation reaction Methods 0.000 description 7
230000008569 process Effects 0.000 description 7
230000028327 secretion Effects 0.000 description 7
229910052710 silicon Inorganic materials 0.000 description 7
239000010703 silicon Substances 0.000 description 7
230000009885 systemic effect Effects 0.000 description 7
238000002560 therapeutic procedure Methods 0.000 description 7
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
208000027418 Wounds and injury Diseases 0.000 description 6
229940035674 anesthetics Drugs 0.000 description 6
239000003990 capacitor Substances 0.000 description 6
238000010586 diagram Methods 0.000 description 6
230000004438 eyesight Effects 0.000 description 6
239000003193 general anesthetic agent Substances 0.000 description 6
230000006698 induction Effects 0.000 description 6
208000014674 injury Diseases 0.000 description 6
210000003733 optic disk Anatomy 0.000 description 6
230000035699 permeability Effects 0.000 description 6
229920000642 polymer Polymers 0.000 description 6
230000005855 radiation Effects 0.000 description 6
238000002604 ultrasonography Methods 0.000 description 6
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 5
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
238000013459 approach Methods 0.000 description 5
238000004159 blood analysis Methods 0.000 description 5
238000009530 blood pressure measurement Methods 0.000 description 5
210000004027 cell Anatomy 0.000 description 5
238000007796 conventional method Methods 0.000 description 5
230000000875 corresponding effect Effects 0.000 description 5
208000035475 disorder Diseases 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
230000003993 interaction Effects 0.000 description 5
150000002632 lipids Chemical class 0.000 description 5
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 5
229910052753 mercury Inorganic materials 0.000 description 5
238000006213 oxygenation reaction Methods 0.000 description 5
229910052697 platinum Inorganic materials 0.000 description 5
229920001296 polysiloxane Polymers 0.000 description 5
239000011343 solid material Substances 0.000 description 5
241000894007 species Species 0.000 description 5
238000011282 treatment Methods 0.000 description 5
230000002792 vascular Effects 0.000 description 5
201000004569 Blindness Diseases 0.000 description 4
RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
102000001554 Hemoglobins Human genes 0.000 description 4
108010054147 Hemoglobins Proteins 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
230000002159 abnormal effect Effects 0.000 description 4
-1 acid-lactic Substances 0.000 description 4
230000003321 amplification Effects 0.000 description 4
230000002238 attenuated effect Effects 0.000 description 4
230000036770 blood supply Effects 0.000 description 4
230000000747 cardiac effect Effects 0.000 description 4
239000013626 chemical specie Substances 0.000 description 4
238000000576 coating method Methods 0.000 description 4
230000001419 dependent effect Effects 0.000 description 4
206010012601 diabetes mellitus Diseases 0.000 description 4
238000012377 drug delivery Methods 0.000 description 4
230000004406 elevated intraocular pressure Effects 0.000 description 4
230000002255 enzymatic effect Effects 0.000 description 4
238000006911 enzymatic reaction Methods 0.000 description 4
230000001815 facial effect Effects 0.000 description 4
239000000017 hydrogel Substances 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
239000013307 optical fiber Substances 0.000 description 4
239000000047 product Substances 0.000 description 4
230000008929 regeneration Effects 0.000 description 4
238000011069 regeneration method Methods 0.000 description 4
238000011160 research Methods 0.000 description 4
238000000926 separation method Methods 0.000 description 4
229910052709 silver Inorganic materials 0.000 description 4
239000004332 silver Substances 0.000 description 4
238000001356 surgical procedure Methods 0.000 description 4
208000030507 AIDS Diseases 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
108010089254 Cholesterol oxidase Proteins 0.000 description 3
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
241001272720 Medialuna californiensis Species 0.000 description 3
208000022873 Ocular disease Diseases 0.000 description 3
108010055297 Sterol Esterase Proteins 0.000 description 3
102000000019 Sterol Esterase Human genes 0.000 description 3
241000700605 Viruses Species 0.000 description 3
230000001133 acceleration Effects 0.000 description 3
238000004026 adhesive bonding Methods 0.000 description 3
239000000427 antigen Substances 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
230000004872 arterial blood pressure Effects 0.000 description 3
210000001367 artery Anatomy 0.000 description 3
230000004888 barrier function Effects 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
238000011088 calibration curve Methods 0.000 description 3
229910002092 carbon dioxide Inorganic materials 0.000 description 3
239000001569 carbon dioxide Substances 0.000 description 3
230000003197 catalytic effect Effects 0.000 description 3
230000004087 circulation Effects 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
230000000295 complement effect Effects 0.000 description 3
230000008602 contraction Effects 0.000 description 3
208000021921 corneal disease Diseases 0.000 description 3
239000013078 crystal Substances 0.000 description 3
230000009849 deactivation Effects 0.000 description 3
238000003745 diagnosis Methods 0.000 description 3
239000000174 gluconic acid Substances 0.000 description 3
235000012208 gluconic acid Nutrition 0.000 description 3
239000005556 hormone Substances 0.000 description 3
229940088597 hormone Drugs 0.000 description 3
230000001939 inductive effect Effects 0.000 description 3
238000007917 intracranial administration Methods 0.000 description 3
238000002483 medication Methods 0.000 description 3
201000001441 melanoma Diseases 0.000 description 3
244000005700 microbiome Species 0.000 description 3
210000001636 ophthalmic artery Anatomy 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
230000016087 ovulation Effects 0.000 description 3
239000004033 plastic Substances 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
239000004926 polymethyl methacrylate Substances 0.000 description 3
238000003825 pressing Methods 0.000 description 3
230000003016 quadriplegic effect Effects 0.000 description 3
231100000241 scar Toxicity 0.000 description 3
239000004065 semiconductor Substances 0.000 description 3
230000035488 systolic blood pressure Effects 0.000 description 3
238000012546 transfer Methods 0.000 description 3
230000032258 transport Effects 0.000 description 3
210000004881 tumor cell Anatomy 0.000 description 3
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
208000003174 Brain Neoplasms Diseases 0.000 description 2
206010006187 Breast cancer Diseases 0.000 description 2
208000026310 Breast neoplasm Diseases 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
102000016938 Catalase Human genes 0.000 description 2
108010053835 Catalase Proteins 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
102100026121 Flap endonuclease 1 Human genes 0.000 description 2
101000913035 Homo sapiens Flap endonuclease 1 Proteins 0.000 description 2
206010021143 Hypoxia Diseases 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
208000008839 Kidney Neoplasms Diseases 0.000 description 2
GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
108090000854 Oxidoreductases Proteins 0.000 description 2
102000004316 Oxidoreductases Human genes 0.000 description 2
241000083513 Punctum Species 0.000 description 2
201000007737 Retinal degeneration Diseases 0.000 description 2
206010039580 Scar Diseases 0.000 description 2
229910021607 Silver chloride Inorganic materials 0.000 description 2
206010052428 Wound Diseases 0.000 description 2
230000005856 abnormality Effects 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
230000036772 blood pressure Effects 0.000 description 2
210000000481 breast Anatomy 0.000 description 2
210000005252 bulbus oculi Anatomy 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
210000001715 carotid artery Anatomy 0.000 description 2
230000002490 cerebral effect Effects 0.000 description 2
GGCLNOIGPMGLDB-GYKMGIIDSA-N cholest-5-en-3-one Chemical compound C1C=C2CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 GGCLNOIGPMGLDB-GYKMGIIDSA-N 0.000 description 2
NYOXRYYXRWJDKP-UHFFFAOYSA-N cholestenone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 NYOXRYYXRWJDKP-UHFFFAOYSA-N 0.000 description 2
150000001840 cholesterol esters Chemical class 0.000 description 2
210000004240 ciliary body Anatomy 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 2
238000013016 damping Methods 0.000 description 2
230000002950 deficient Effects 0.000 description 2
230000005347 demagnetization Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
230000035487 diastolic blood pressure Effects 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
229910001882 dioxygen Inorganic materials 0.000 description 2
230000000857 drug effect Effects 0.000 description 2
230000009977 dual effect Effects 0.000 description 2
230000005684 electric field Effects 0.000 description 2
210000000981 epithelium Anatomy 0.000 description 2
238000005562 fading Methods 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 2
235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
239000011714 flavin adenine dinucleotide Substances 0.000 description 2
229940093632 flavin-adenine dinucleotide Drugs 0.000 description 2
210000003128 head Anatomy 0.000 description 2
230000036541 health Effects 0.000 description 2
230000003862 health status Effects 0.000 description 2
230000007954 hypoxia Effects 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
230000002427 irreversible effect Effects 0.000 description 2
238000002372 labelling Methods 0.000 description 2
208000020816 lung neoplasm Diseases 0.000 description 2
208000037841 lung tumor Diseases 0.000 description 2
208000002780 macular degeneration Diseases 0.000 description 2
230000005415 magnetization Effects 0.000 description 2
230000005499 meniscus Effects 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
239000000203 mixture Substances 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
210000004126 nerve fiber Anatomy 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
230000037311 normal skin Effects 0.000 description 2
230000010355 oscillation Effects 0.000 description 2
210000000496 pancreas Anatomy 0.000 description 2
244000052769 pathogen Species 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
239000008188 pellet Substances 0.000 description 2
239000002574 poison Substances 0.000 description 2
231100000614 poison Toxicity 0.000 description 2
230000002265 prevention Effects 0.000 description 2
230000000750 progressive effect Effects 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
235000018102 proteins Nutrition 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
210000001747 pupil Anatomy 0.000 description 2
238000011002 quantification Methods 0.000 description 2
239000010453 quartz Substances 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
230000029058 respiratory gaseous exchange Effects 0.000 description 2
230000000284 resting effect Effects 0.000 description 2
210000001927 retinal artery Anatomy 0.000 description 2
230000004258 retinal degeneration Effects 0.000 description 2
230000033764 rhythmic process Effects 0.000 description 2
210000003296 saliva Anatomy 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
238000007619 statistical method Methods 0.000 description 2
238000012619 stoichiometric conversion Methods 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000004393 visual impairment Effects 0.000 description 2
206010000369 Accident Diseases 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
208000025679 Bell phenomenon Diseases 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
208000014644 Brain disease Diseases 0.000 description 1
206010006322 Breath holding Diseases 0.000 description 1
241001631457 Cannula Species 0.000 description 1
UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
208000014882 Carotid artery disease Diseases 0.000 description 1
208000026005 Central nervous system vascular disease Diseases 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
206010011469 Crying Diseases 0.000 description 1
108020004414 DNA Proteins 0.000 description 1
108091006149 Electron carriers Proteins 0.000 description 1
208000001860 Eye Infections Diseases 0.000 description 1
YPZRHBJKEMOYQH-UYBVJOGSSA-L FADH2(2-) Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP([O-])(=O)OP([O-])(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C(NC(=O)NC2=O)=C2NC2=C1C=C(C)C(C)=C2 YPZRHBJKEMOYQH-UYBVJOGSSA-L 0.000 description 1
108010088842 Fibrinolysin Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
206010058490 Hyperoxia Diseases 0.000 description 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
108010093096 Immobilized Enzymes Proteins 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
102000011782 Keratins Human genes 0.000 description 1
108010076876 Keratins Proteins 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
102000010445 Lactoferrin Human genes 0.000 description 1
108010063045 Lactoferrin Proteins 0.000 description 1
206010025282 Lymphoedema Diseases 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
240000005561 Musa balbisiana Species 0.000 description 1
235000018290 Musa x paradisiaca Nutrition 0.000 description 1
229920000557 Nafion® Polymers 0.000 description 1
208000012266 Needlestick injury Diseases 0.000 description 1
206010029113 Neovascularisation Diseases 0.000 description 1
208000028389 Nerve injury Diseases 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000014245 Ocular vascular disease Diseases 0.000 description 1
206010033546 Pallor Diseases 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
206010038848 Retinal detachment Diseases 0.000 description 1
206010038933 Retinopathy of prematurity Diseases 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
208000006011 Stroke Diseases 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
206010046914 Vaginal infection Diseases 0.000 description 1
206010047571 Visual impairment Diseases 0.000 description 1
238000005299 abrasion Methods 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000036982 action potential Effects 0.000 description 1
230000032683 aging Effects 0.000 description 1
229940050528 albumin Drugs 0.000 description 1
229910000828 alnico Inorganic materials 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000012491 analyte Substances 0.000 description 1
230000001384 anti-glaucoma Effects 0.000 description 1
208000008784 apnea Diseases 0.000 description 1
229940072107 ascorbate Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
238000000429 assembly Methods 0.000 description 1
230000000712 assembly Effects 0.000 description 1
201000009310 astigmatism Diseases 0.000 description 1
230000003416 augmentation Effects 0.000 description 1
210000003403 autonomic nervous system Anatomy 0.000 description 1
230000003376 axonal effect Effects 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
230000006399 behavior Effects 0.000 description 1
230000002457 bidirectional effect Effects 0.000 description 1
230000002210 biocatalytic effect Effects 0.000 description 1
239000000560 biocompatible material Substances 0.000 description 1
230000000513 bioprotective effect Effects 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
230000036765 blood level Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
229910002091 carbon monoxide Inorganic materials 0.000 description 1
210000004004 carotid artery internal Anatomy 0.000 description 1
238000013172 carotid endarterectomy Methods 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
150000003943 catecholamines Chemical class 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
230000003727 cerebral blood flow Effects 0.000 description 1
208000026106 cerebrovascular disease Diseases 0.000 description 1
238000007600 charging Methods 0.000 description 1
229910052729 chemical element Inorganic materials 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
229910017052 cobalt Inorganic materials 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
239000002131 composite material Substances 0.000 description 1
230000006835 compression Effects 0.000 description 1
238000007906 compression Methods 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000002316 cosmetic surgery Methods 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000007547 defect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000000881 depressing effect Effects 0.000 description 1
230000010339 dilation Effects 0.000 description 1
230000003467 diminishing effect Effects 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
238000002224 dissection Methods 0.000 description 1
238000013399 early diagnosis Methods 0.000 description 1
239000013013 elastic material Substances 0.000 description 1
238000000835 electrochemical detection Methods 0.000 description 1
238000002848 electrochemical method Methods 0.000 description 1
238000003487 electrochemical reaction Methods 0.000 description 1
230000005672 electromagnetic field Effects 0.000 description 1
230000005670 electromagnetic radiation Effects 0.000 description 1
230000003028 elevating effect Effects 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
210000005081 epithelial layer Anatomy 0.000 description 1
210000003560 epithelium corneal Anatomy 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
239000000284 extract Substances 0.000 description 1
208000030533 eye disease Diseases 0.000 description 1
208000011323 eye infectious disease Diseases 0.000 description 1
239000003302 ferromagnetic material Substances 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
239000005357 flat glass Substances 0.000 description 1
238000001595 flow curve Methods 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
239000000446 fuel Substances 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
235000001727 glucose Nutrition 0.000 description 1
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
239000003292 glue Substances 0.000 description 1
BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 1
229960003132 halothane Drugs 0.000 description 1
230000001121 heart beat frequency Effects 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
230000002008 hemorrhagic effect Effects 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000002706 hydrostatic effect Effects 0.000 description 1
230000000222 hyperoxic effect Effects 0.000 description 1
230000001969 hypertrophic effect Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
230000003116 impacting effect Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000004941 influx Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000009413 insulation Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000001788 irregular Effects 0.000 description 1
230000007794 irritation Effects 0.000 description 1
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
229940078795 lactoferrin Drugs 0.000 description 1
235000021242 lactoferrin Nutrition 0.000 description 1
230000003902 lesion Effects 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
210000001232 limbus corneae Anatomy 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000004973 liquid crystal related substance Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000007774 longterm Effects 0.000 description 1
208000018769 loss of vision Diseases 0.000 description 1
231100000864 loss of vision Toxicity 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
208000002502 lymphedema Diseases 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
238000013178 mathematical model Methods 0.000 description 1
238000000691 measurement method Methods 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
239000000155 melt Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
229910044991 metal oxide Inorganic materials 0.000 description 1
150000004706 metal oxides Chemical class 0.000 description 1
238000001465 metallisation Methods 0.000 description 1
239000013081 microcrystal Substances 0.000 description 1
238000004377 microelectronic Methods 0.000 description 1
239000011707 mineral Substances 0.000 description 1
210000002200 mouth mucosa Anatomy 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
238000001320 near-infrared absorption spectroscopy Methods 0.000 description 1
230000001338 necrotic effect Effects 0.000 description 1
230000008764 nerve damage Effects 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
210000003061 neural cell Anatomy 0.000 description 1
239000002547 new drug Substances 0.000 description 1
239000001272 nitrous oxide Substances 0.000 description 1
229910000510 noble metal Inorganic materials 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
238000005457 optimization Methods 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
230000036284 oxygen consumption Effects 0.000 description 1
229960005489 paracetamol Drugs 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
231100000915 pathological change Toxicity 0.000 description 1
230000036285 pathological change Effects 0.000 description 1
230000007310 pathophysiology Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229920003936 perfluorinated ionomer Polymers 0.000 description 1
230000005043 peripheral vision Effects 0.000 description 1
238000006552 photochemical reaction Methods 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
229940012957 plasmin Drugs 0.000 description 1
230000010287 polarization Effects 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
229910001414 potassium ion Inorganic materials 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
230000035485 pulse pressure Effects 0.000 description 1
230000000191 radiation effect Effects 0.000 description 1
239000000376 reactant Substances 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
238000002310 reflectometry Methods 0.000 description 1
238000000611 regression analysis Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000036387 respiratory rate Effects 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
230000000452 restraining effect Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000004264 retinal detachment Effects 0.000 description 1
210000001210 retinal vessel Anatomy 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
230000001020 rhythmical effect Effects 0.000 description 1
230000037390 scarring Effects 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000007789 sealing Methods 0.000 description 1
230000001235 sensitizing effect Effects 0.000 description 1
229920002379 silicone rubber Polymers 0.000 description 1
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
230000036558 skin tension Effects 0.000 description 1
229910001415 sodium ion Inorganic materials 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
208000020431 spinal cord injury Diseases 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
230000035882 stress Effects 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
210000004243 sweat Anatomy 0.000 description 1
230000008961 swelling Effects 0.000 description 1
210000002820 sympathetic nervous system Anatomy 0.000 description 1
230000001360 synchronised effect Effects 0.000 description 1
230000008337 systemic blood flow Effects 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
238000012956 testing procedure Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000000451 tissue damage Effects 0.000 description 1
231100000827 tissue damage Toxicity 0.000 description 1
230000008354 tissue degradation Effects 0.000 description 1
210000001585 trabecular meshwork Anatomy 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
230000008733 trauma Effects 0.000 description 1
230000000472 traumatic effect Effects 0.000 description 1
238000011277 treatment modality Methods 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
208000019553 vascular disease Diseases 0.000 description 1
230000008728 vascular permeability Effects 0.000 description 1
208000029257 vision disease Diseases 0.000 description 1
230000004304 visual acuity Effects 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
230000001755 vocal effect Effects 0.000 description 1
239000003643 water by type Substances 0.000 description 1
239000001993 wax Substances 0.000 description 1
238000004804 winding Methods 0.000 description 1
238000010626 work up procedure Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
- A61B3/1241—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes specially adapted for observation of ocular blood flow, e.g. by fluorescein angiography
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/16—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring intraocular pressure, e.g. tonometers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring pH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
- A61B2560/0219—Operational features of power management of power generation or supply of externally powered implanted units
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
- A61B2560/0247—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value
- A61B2560/0252—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value using ambient temperature
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0406—Constructional details of apparatus specially shaped apparatus housings
- A61B2560/0418—Pen-shaped housings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0233—Special features of optical sensors or probes classified in A61B5/00
- A61B2562/0238—Optical sensor arrangements for performing transmission measurements on body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure ; Measuring pressure in body tissues or organs
- A61B5/031—Intracranial pressure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14555—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for the eye fundus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/18—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state for vehicle drivers or machine operators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Physics & Mathematics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Surgery (AREA)
Medical Informatics (AREA)
Biophysics (AREA)
Pathology (AREA)
Optics & Photonics (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Dermatology (AREA)
Computer Networks & Wireless Communication (AREA)
Emergency Medicine (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Radiology & Medical Imaging (AREA)
Spectroscopy & Molecular Physics (AREA)
Eye Examination Apparatus (AREA)
Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

IL12882597A 1996-09-04 1997-09-04 Pressure gauge system for measuring intraocular pressure by flattening and / or a notch IL128825A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/707,508 US5830139A (en)	1996-09-04	1996-09-04	Tonometer system for measuring intraocular pressure by applanation and/or indentation
PCT/US1997/015489 WO1998009564A1 (fr)	1996-09-04	1997-09-04	Systeme de tonometre destine a mesurer la pression intraoculaire par aplanation et/ou penetration
US09/184,127 US6120460A (en)	1996-09-04	1998-11-02	Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions

Publications (2)

Publication Number	Publication Date
IL128825A0 IL128825A0 (en)	2000-01-31
IL128825A true IL128825A (en)	2004-07-25

Family

ID=24841992

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12882597A IL128825A (en)	1996-09-04	1997-09-04	Pressure gauge system for measuring intraocular pressure by flattening and / or a notch

Country Status (10)

Country	Link
US (1)	US5830139A (fr)
EP (1)	EP0926979A4 (fr)
JP (1)	JP2000517231A (fr)
KR (1)	KR100411363B1 (fr)
CN (1)	CN1229345A (fr)
AU (1)	AU741461B2 (fr)
BR (1)	BR9711993C1 (fr)
CA (1)	CA2264193C (fr)
IL (1)	IL128825A (fr)
WO (1)	WO1998009564A1 (fr)

Families Citing this family (234)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6405069B1 (en) *	1996-01-31	2002-06-11	Board Of Regents, The University Of Texas System	Time-resolved optoacoustic method and system for noninvasive monitoring of glucose
US6120460A (en) *	1996-09-04	2000-09-19	Abreu; Marcio Marc	Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions
US6544193B2 (en) *	1996-09-04	2003-04-08	Marcio Marc Abreu	Noninvasive measurement of chemical substances
US6018673A (en)	1996-10-10	2000-01-25	Nellcor Puritan Bennett Incorporated	Motion compatible sensor for non-invasive optical blood analysis
US9468378B2 (en)	1997-01-27	2016-10-18	Lawrence A. Lynn	Airway instability detection system and method
US8932227B2 (en)	2000-07-28	2015-01-13	Lawrence A. Lynn	System and method for CO2 and oximetry integration
US9042952B2 (en)	1997-01-27	2015-05-26	Lawrence A. Lynn	System and method for automatic detection of a plurality of SPO2 time series pattern types
US20070191697A1 (en)	2006-02-10	2007-08-16	Lynn Lawrence A	System and method for SPO2 instability detection and quantification
US9521971B2 (en)	1997-07-14	2016-12-20	Lawrence A. Lynn	System and method for automatic detection of a plurality of SPO2 time series pattern types
US5954645A (en) *	1998-04-03	1999-09-21	Leica Microsystems Inc.	Applanation detection system for a non-contact tonometer
WO1999065387A1 (fr) *	1998-06-19	1999-12-23	Uab Research Foundation	Tonometre d'oxymetrie avec capacite de mesure de la pression intracranienne
GB9816011D0 (en) *	1998-07-22	1998-09-23	Habib Nagy A	Monitoring treatment using implantable telemetric sensors
GB9816012D0 (en)	1998-07-22	1998-09-23	Habib Nagy A	Treatment using implantable devices
US6045503A (en) *	1999-01-20	2000-04-04	Kamilllo Eisner-Stiftung	Method of and apparatus for determining the topology of a cornea
US6675031B1 (en)	1999-04-14	2004-01-06	Mallinckrodt Inc.	Method and circuit for indicating quality and accuracy of physiological measurements
MXPA01010830A (es)	1999-04-26	2003-07-14	Gmp Vision Solutions Inc	Dispositivo inflable y metodo para el tratamiento del glaucoma.
MXPA02002029A (es) *	1999-08-26	2002-08-20	Novartis Ag	Detector de analito ocular.
US6939299B1 (en)	1999-12-13	2005-09-06	Kurt Petersen	Implantable continuous intraocular pressure sensor
ES2161639B1 (es) *	2000-01-11	2002-10-01	Diego Luis Fernandez-Vega	Tonometro ocular epipalpebral o corneal
DE10000669C2 (de) *	2000-01-11	2002-02-28	Airbus Gmbh	Luftmassenstromregelsystem mit Druckhöhenkorrektur für ein Verkehrsflugzeug
US7867186B2 (en)	2002-04-08	2011-01-11	Glaukos Corporation	Devices and methods for treatment of ocular disorders
US6638239B1 (en)	2000-04-14	2003-10-28	Glaukos Corporation	Apparatus and method for treating glaucoma
US7708711B2 (en)	2000-04-14	2010-05-04	Glaukos Corporation	Ocular implant with therapeutic agents and methods thereof
JP2003532473A (ja) *	2000-05-08	2003-11-05	ネステックオフタルミックシステムズエル・ティー・ディー	眼内圧検査
US6447449B1 (en)	2000-08-21	2002-09-10	Cleveland Clinic Foundation	System for measuring intraocular pressure of an eye and a MEM sensor for use therewith
US6994672B2 (en) *	2000-08-21	2006-02-07	Cleveland Clinic Foundation	Apparatus and method for measuring intraocular pressure
US6749568B2 (en) *	2000-08-21	2004-06-15	Cleveland Clinic Foundation	Intraocular pressure measurement system including a sensor mounted in a contact lens
US9053222B2 (en)	2002-05-17	2015-06-09	Lawrence A. Lynn	Patient safety processor
US20060195041A1 (en)	2002-05-17	2006-08-31	Lynn Lawrence A	Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions
US6666841B2 (en)	2001-05-02	2003-12-23	Glaukos Corporation	Bifurcatable trabecular shunt for glaucoma treatment
US7431710B2 (en)	2002-04-08	2008-10-07	Glaukos Corporation	Ocular implants with anchors and methods thereof
US6981958B1 (en)	2001-05-02	2006-01-03	Glaukos Corporation	Implant with pressure sensor for glaucoma treatment
CA2683224C (fr)	2001-04-07	2014-12-02	Glaukos Corporation	Systeme et methodes connexes de traitement des affections oculaires
US7488303B1 (en)	2002-09-21	2009-02-10	Glaukos Corporation	Ocular implant with anchor and multiple openings
US6893398B2 (en) *	2001-04-19	2005-05-17	Odc Ophthalmic Development Company Ag	Device for measuring intraocular pressure, in particular a tonometer
US7678065B2 (en)	2001-05-02	2010-03-16	Glaukos Corporation	Implant with intraocular pressure sensor for glaucoma treatment
US7094225B2 (en) *	2001-05-03	2006-08-22	Glaukos Corporation	Medical device and methods of use of glaucoma treatment
US6706001B2 (en) *	2001-05-11	2004-03-16	Bernard B. Fresco	Dual tonometer pressure measurement device
US6776756B2 (en)	2001-05-16	2004-08-17	Marco Ophthalmic, Inc.	Applanation tonometer
DE60117792T2 (de) *	2001-06-29	2006-11-23	Ecole polytechnique fédérale de Lausanne (EPFL)	Vorrichtung zur messung des intraokularen druckes
US6754516B2 (en)	2001-07-19	2004-06-22	Nellcor Puritan Bennett Incorporated	Nuisance alarm reductions in a physiological monitor
DE10135944C2 (de) *	2001-07-24	2003-10-02	Med Laserzentrum Luebeck Gmbh	Verfahren und Vorrichtung zur nichtinvasiven Bestimmung der Temperatur an mit einer Strahlung, insbesondere Laserstrahlung behandeltem biologischem Gewebe
GB2378770B (en) *	2001-08-14	2004-02-25	Keeler Ltd	Hand held tonometer with optical arrangement for indicating critical distance from an eye
US7331984B2 (en)	2001-08-28	2008-02-19	Glaukos Corporation	Glaucoma stent for treating glaucoma and methods of use
US20030097151A1 (en) *	2001-10-25	2003-05-22	Smedley Gregory T.	Apparatus and mitochondrial treatment for glaucoma
US7163543B2 (en) *	2001-11-08	2007-01-16	Glaukos Corporation	Combined treatment for cataract and glaucoma treatment
US6923765B2 (en) *	2001-11-21	2005-08-02	A. Mateen Ahmed	Tonometer and method of use
US7186232B1 (en)	2002-03-07	2007-03-06	Glaukoa Corporation	Fluid infusion methods for glaucoma treatment
US20030179094A1 (en) *	2002-03-08	2003-09-25	Abreu Marcio Marc	Signal-to-product coupling
US7951155B2 (en)	2002-03-15	2011-05-31	Glaukos Corporation	Combined treatment for cataract and glaucoma treatment
US9301875B2 (en)	2002-04-08	2016-04-05	Glaukos Corporation	Ocular disorder treatment implants with multiple opening
US8849379B2 (en) *	2002-04-22	2014-09-30	Geelux Holdings, Ltd.	Apparatus and method for measuring biologic parameters
KR101124852B1 (ko)	2002-04-22	2012-03-28	마시오 마크 아우렐리오 마틴스 애브리우	생물학적 파라미터 측정 장치 및 방법
US8328420B2 (en)	2003-04-22	2012-12-11	Marcio Marc Abreu	Apparatus and method for measuring biologic parameters
US10123732B2 (en)	2002-04-22	2018-11-13	Geelux Holdings, Ltd.	Apparatus and method for measuring biologic parameters
US20040058313A1 (en) *	2002-04-24	2004-03-25	Abreu Marcio Marc	Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
US20050137474A1 (en) *	2002-06-17	2005-06-23	Antti Kontiola	Method for measuring intraocular pressure
US20050137473A1 (en) *	2002-06-17	2005-06-23	Antti Kontiola	Apparatus for measuring intraocular pressure
US7473231B2 (en) *	2002-06-25	2009-01-06	Francis Y. Falck	Method and apparatus for examining an eye
DE50200286D1 (de) *	2002-06-27	2004-04-15	Sis Ag Surgical Instr Systems	Vorrichtung zur Erfassung von Messwerten an einem Auge
US7131945B2 (en) *	2002-10-16	2006-11-07	California Institute Of Technology	Optically powered and optically data-transmitting wireless intraocular pressure sensor device
AU2003284295A1 (en) *	2002-10-18	2004-05-04	Eyelab Group, Llc	Apparatus and method for self-measurement of intraocular pressure
US20040111133A1 (en) *	2002-12-10	2004-06-10	Alcon, Inc.	LED illuminator
US7006856B2 (en)	2003-01-10	2006-02-28	Nellcor Puritan Bennett Incorporated	Signal quality metrics design for qualifying data for a physiological monitor
US7016715B2 (en)	2003-01-13	2006-03-21	Nellcorpuritan Bennett Incorporated	Selection of preset filter parameters based on signal quality
US7122007B2 (en) *	2003-05-12	2006-10-17	Caritas St. Elizabeth Medical Center Of Boston, Inc.	Methods of and systems and devices for assessing intracranial pressure non-invasively
US20050030473A1 (en) *	2003-06-12	2005-02-10	Welch Allyn, Inc.	Apparatus and method for determining intraocular pressure and corneal thickness
US7204806B2 (en) *	2003-06-17	2007-04-17	Mitsugu Shimmyo	Method and apparatus for obtaining corrected intraocular pressure values
US8128606B2 (en) *	2003-07-03	2012-03-06	Hewlett-Packard Development Company, L.P.	Ophthalmic apparatus and method for administering agents to the eye
US7575321B2 (en)	2003-10-30	2009-08-18	Welch Allyn, Inc.	Apparatus and method of diagnosis of optically identifiable ophthalmic conditions
US7708403B2 (en)	2003-10-30	2010-05-04	Welch Allyn, Inc.	Apparatus and method for diagnosis of optically identifiable ophthalmic conditions
US20090270717A1 (en) *	2008-04-25	2009-10-29	Welch Allyn, Inc.	Apparatus and method for diagnosis of optically identifiable ophthalmic conditions
US7190985B2 (en)	2004-02-25	2007-03-13	Nellcor Puritan Bennett Inc.	Oximeter ambient light cancellation
US7120479B2 (en)	2004-02-25	2006-10-10	Nellcor Puritan Bennett Inc.	Switch-mode oximeter LED drive with a single inductor
US10227063B2 (en)	2004-02-26	2019-03-12	Geelux Holdings, Ltd.	Method and apparatus for biological evaluation
JP2007527750A (ja) *	2004-03-06	2007-10-04	カリストメディカル，インク．	生体内物質の量的情報を非侵襲的に測定する方法及びデバイス
US8611977B2 (en) *	2004-03-08	2013-12-17	Covidien Lp	Method and apparatus for optical detection of mixed venous and arterial blood pulsation in tissue
US7534212B2 (en)	2004-03-08	2009-05-19	Nellcor Puritan Bennett Llc	Pulse oximeter with alternate heart-rate determination
US7194293B2 (en)	2004-03-08	2007-03-20	Nellcor Puritan Bennett Incorporated	Selection of ensemble averaging weights for a pulse oximeter based on signal quality metrics
US7277741B2 (en)	2004-03-09	2007-10-02	Nellcor Puritan Bennett Incorporated	Pulse oximetry motion artifact rejection using near infrared absorption by water
JP4583801B2 (ja) *	2004-04-23	2010-11-17	学校法人早稲田大学	圧力測定方法および圧力測定装置ならびに眼圧計
US20060019331A1 (en) *	2004-07-20	2006-01-26	Gideon Eden	Method and system for generating a telephone alert indicating the presence of an analyte
US7595170B2 (en) *	2004-08-05	2009-09-29	Modrovich Ivan E	Apparatus and method for measuring concentrations of molecules through a barrier
US20060135864A1 (en) *	2004-11-24	2006-06-22	Westerlund L E	Peri-orbital trauma monitor and ocular pressure / peri-orbital edema monitor for non-ophthalmic surgery
DE102004062337B4 (de) *	2004-12-20	2010-09-30	Mechatronic Ag	Mobiles Tonometer zur Durchführung einer berührungsfreien Selbsttonometrie
IL166962A (en) *	2005-02-17	2012-06-28	Ait Advanced Medical Technologies Ltd	Device and method for intra-ocular pressure measurment
US7392075B2 (en)	2005-03-03	2008-06-24	Nellcor Puritan Bennett Incorporated	Method for enhancing pulse oximetry calculations in the presence of correlated artifacts
US7725146B2 (en)	2005-09-29	2010-05-25	Nellcor Puritan Bennett Llc	System and method for pre-processing waveforms
US7725147B2 (en)	2005-09-29	2010-05-25	Nellcor Puritan Bennett Llc	System and method for removing artifacts from waveforms
US20070106126A1 (en)	2005-09-30	2007-05-10	Mannheimer Paul D	Patient monitoring alarm escalation system and method
WO2007041871A2 (fr) *	2005-10-14	2007-04-19	Starfish Products Engineering Inc.	Capteurs de pression et procedes de mesure
US20090203985A1 (en) *	2005-10-14	2009-08-13	Ehrecke Timothy J	Pressure Monitor
DK1951110T3 (da)	2005-10-24	2013-01-21	Marcio Marc Aurelio Martins Abreu	Apparatur til måling af biologiske parametre
US20070100220A1 (en)	2005-10-28	2007-05-03	Baker Clark R Jr	Adjusting parameters used in pulse oximetry analysis
US20070123768A1 (en) *	2005-11-30	2007-05-31	Duke University	Ophthalmic instruments, systems and methods especially adapted for conducting simultaneous tonometry and pachymetry measurements
US7668579B2 (en)	2006-02-10	2010-02-23	Lynn Lawrence A	System and method for the detection of physiologic response to stimulation
US8702606B2 (en)	2006-03-21	2014-04-22	Covidien Lp	Patient monitoring help video system and method
US20070236213A1 (en) *	2006-03-30	2007-10-11	Paden Bradley E	Telemetry method and apparatus using magnetically-driven mems resonant structure
US8380271B2 (en)	2006-06-15	2013-02-19	Covidien Lp	System and method for generating customizable audible beep tones and alarms
US8064975B2 (en)	2006-09-20	2011-11-22	Nellcor Puritan Bennett Llc	System and method for probability based determination of estimated oxygen saturation
US8696593B2 (en)	2006-09-27	2014-04-15	Covidien Lp	Method and system for monitoring intracranial pressure
US7922665B2 (en)	2006-09-28	2011-04-12	Nellcor Puritan Bennett Llc	System and method for pulse rate calculation using a scheme for alternate weighting
US8175667B2 (en)	2006-09-29	2012-05-08	Nellcor Puritan Bennett Llc	Symmetric LED array for pulse oximetry
US8160668B2 (en)	2006-09-29	2012-04-17	Nellcor Puritan Bennett Llc	Pathological condition detector using kernel methods and oximeters
US20080082057A1 (en) *	2006-09-29	2008-04-03	Korb Donald R	Method and apparatus for diagnosing meibomian gland dysfunction
US7706896B2 (en)	2006-09-29	2010-04-27	Nellcor Puritan Bennett Llc	User interface and identification in a medical device system and method
US7698002B2 (en)	2006-09-29	2010-04-13	Nellcor Puritan Bennett Llc	Systems and methods for user interface and identification in a medical device
US7848891B2 (en)	2006-09-29	2010-12-07	Nellcor Puritan Bennett Llc	Modulation ratio determination with accommodation of uncertainty
US8068890B2 (en)	2006-09-29	2011-11-29	Nellcor Puritan Bennett Llc	Pulse oximetry sensor switchover
US7925511B2 (en)	2006-09-29	2011-04-12	Nellcor Puritan Bennett Llc	System and method for secure voice identification in a medical device
US20080081956A1 (en)	2006-09-29	2008-04-03	Jayesh Shah	System and method for integrating voice with a medical device
US8728059B2 (en)	2006-09-29	2014-05-20	Covidien Lp	System and method for assuring validity of monitoring parameter in combination with a therapeutic device
US8068891B2 (en)	2006-09-29	2011-11-29	Nellcor Puritan Bennett Llc	Symmetric LED array for pulse oximetry
US8506515B2 (en)	2006-11-10	2013-08-13	Glaukos Corporation	Uveoscleral shunt and methods for implanting same
DE102007003341B4 (de)	2007-01-17	2018-01-04	Eyesense Ag	Okularsensor und Messsystem zum Nachweis eines Analyten in einer Augenflüssigkeit
US8265724B2 (en)	2007-03-09	2012-09-11	Nellcor Puritan Bennett Llc	Cancellation of light shunting
US7682027B2 (en) *	2007-04-09	2010-03-23	Alcon, Inc.	Multi-LED ophthalmic illuminator
US8992516B2 (en)	2007-07-19	2015-03-31	Avedro, Inc.	Eye therapy system
US8202272B2 (en)	2007-07-19	2012-06-19	Avedro, Inc.	Eye therapy system
JP4569615B2 (ja) *	2007-09-25	2010-10-27	ブラザー工業株式会社	印刷装置
US8204567B2 (en)	2007-12-13	2012-06-19	Nellcor Puritan Bennett Llc	Signal demodulation
US7802883B2 (en)	2007-12-20	2010-09-28	Johnson & Johnson Vision Care, Inc.	Cosmetic contact lenses having a sparkle effect
US8092993B2 (en)	2007-12-31	2012-01-10	Nellcor Puritan Bennett Llc	Hydrogel thin film for use as a biosensor
US8469952B2 (en) *	2008-01-23	2013-06-25	Avedro, Inc.	System and method for positioning an eye therapy device
US8409189B2 (en) *	2008-01-23	2013-04-02	Avedro, Inc.	System and method for reshaping an eye feature
US8348935B2 (en)	2008-01-23	2013-01-08	Avedro, Inc.	System and method for reshaping an eye feature
US8750953B2 (en)	2008-02-19	2014-06-10	Covidien Lp	Methods and systems for alerting practitioners to physiological conditions
US8275553B2 (en)	2008-02-19	2012-09-25	Nellcor Puritan Bennett Llc	System and method for evaluating physiological parameter data
KR100936047B1 (ko)	2008-03-03	2010-01-08	한국표준과학연구원	안압계 테스팅 장치
WO2009111726A2 (fr) *	2008-03-06	2009-09-11	The Regents Of The University Of California	Mesure de la résistance/facilité d'un œil face au débordement
US8140272B2 (en)	2008-03-27	2012-03-20	Nellcor Puritan Bennett Llc	System and method for unmixing spectroscopic observations with nonnegative matrix factorization
US8437822B2 (en)	2008-03-28	2013-05-07	Covidien Lp	System and method for estimating blood analyte concentration
US8364224B2 (en)	2008-03-31	2013-01-29	Covidien Lp	System and method for facilitating sensor and monitor communication
US8292809B2 (en)	2008-03-31	2012-10-23	Nellcor Puritan Bennett Llc	Detecting chemical components from spectroscopic observations
US8112375B2 (en)	2008-03-31	2012-02-07	Nellcor Puritan Bennett Llc	Wavelength selection and outlier detection in reduced rank linear models
US20090275936A1 (en) *	2008-05-01	2009-11-05	David Muller	System and method for applying therapy to an eye using energy conduction
EP2283443A1 (fr)	2008-05-07	2011-02-16	Lynn, Lawrence A.	Moteur de recherche de modèle d' échec médical
US9895068B2 (en)	2008-06-30	2018-02-20	Covidien Lp	Pulse oximeter with wait-time indication
USD626562S1 (en)	2008-06-30	2010-11-02	Nellcor Puritan Bennett Llc	Triangular saturation pattern detection indicator for a patient monitor display panel
USD626561S1 (en)	2008-06-30	2010-11-02	Nellcor Puritan Bennett Llc	Circular satseconds indicator and triangular saturation pattern detection indicator for a patient monitor display panel
US20100152565A1 (en) *	2008-07-15	2010-06-17	Thomas Gordon A	Non-invasive tonometer
EP2346457A4 (fr) *	2008-09-19	2012-03-07	Avedro Inc	Système de thérapie de l' il
US8386000B2 (en)	2008-09-30	2013-02-26	Covidien Lp	System and method for photon density wave pulse oximetry and pulse hemometry
US8968193B2 (en)	2008-09-30	2015-03-03	Covidien Lp	System and method for enabling a research mode on physiological monitors
US8417309B2 (en)	2008-09-30	2013-04-09	Covidien Lp	Medical sensor
US8433382B2 (en)	2008-09-30	2013-04-30	Covidien Lp	Transmission mode photon density wave system and method
JP2012504472A (ja) *	2008-10-01	2012-02-23	アヴェドロ・インコーポレーテッド	眼治療システム
US20100113908A1 (en) *	2008-10-31	2010-05-06	Nellcor Puritan Bennett Llc	System And Method For Facilitating Observation Of Monitored Physiologic Data
CA2741026C (fr)	2008-10-31	2015-04-14	Nellcor Puritan Bennett Llc	Systeme et procede permettant de faciliter l'observation de donnees physiologiques regulees
GB2464981A (en) *	2008-11-01	2010-05-05	Univ Dundee	Pressure sensor for measuring intraocular pressure that can be worn on the eye.
WO2010056848A1 (fr) *	2008-11-11	2010-05-20	Avedro, Inc.	Système de thérapie oculaire
US8221319B2 (en)	2009-03-25	2012-07-17	Nellcor Puritan Bennett Llc	Medical device for assessing intravascular blood volume and technique for using the same
US20100256626A1 (en) *	2009-04-02	2010-10-07	Avedro, Inc.	Eye therapy system
WO2010115121A1 (fr)	2009-04-02	2010-10-07	Avedro, Inc.	Système de thérapie oculaire
US8509869B2 (en)	2009-05-15	2013-08-13	Covidien Lp	Method and apparatus for detecting and analyzing variations in a physiologic parameter
US8494786B2 (en)	2009-07-30	2013-07-23	Covidien Lp	Exponential sampling of red and infrared signals
US8494606B2 (en)	2009-08-19	2013-07-23	Covidien Lp	Photoplethysmography with controlled application of sensor pressure
US7959570B2 (en) *	2009-08-31	2011-06-14	Eniko Todorov Enikov	Eye tonometry apparatus, systems and methods
SE0950648A1 (sv) *	2009-09-10	2011-03-11	Bioresonator Ab	Ett förfarande, en anordning, en ögontrycksmätare samt användning
US8704666B2 (en)	2009-09-21	2014-04-22	Covidien Lp	Medical device interface customization systems and methods
US8494604B2 (en)	2009-09-21	2013-07-23	Covidien Lp	Wavelength-division multiplexing in a multi-wavelength photon density wave system
US8788001B2 (en)	2009-09-21	2014-07-22	Covidien Lp	Time-division multiplexing in a multi-wavelength photon density wave system
US8798704B2 (en)	2009-09-24	2014-08-05	Covidien Lp	Photoacoustic spectroscopy method and system to discern sepsis from shock
US8923945B2 (en)	2009-09-24	2014-12-30	Covidien Lp	Determination of a physiological parameter
US8571621B2 (en) *	2009-09-24	2013-10-29	Covidien Lp	Minimax filtering for pulse oximetry
CA2771856A1 (fr)	2009-09-24	2011-03-31	Nellcor Puritan Bennett Llc	Determination d'un parametre physiologique
US9554739B2 (en)	2009-09-29	2017-01-31	Covidien Lp	Smart cable for coupling a medical sensor to an electronic patient monitor
US8376955B2 (en)	2009-09-29	2013-02-19	Covidien Lp	Spectroscopic method and system for assessing tissue temperature
US8515511B2 (en)	2009-09-29	2013-08-20	Covidien Lp	Sensor with an optical coupling material to improve plethysmographic measurements and method of using the same
US8401608B2 (en) *	2009-09-30	2013-03-19	Covidien Lp	Method of analyzing photon density waves in a medical monitor
US20110087086A1 (en) *	2009-10-12	2011-04-14	Falck Medical, Inc.	Method of Estimating Ocular Perfusion Pressure
WO2011053768A2 (fr) *	2009-10-30	2011-05-05	Avedro, Inc.	Système et procédé pour stabiliser des tissus cornéens après traitement
CN102655803A (zh) *	2009-12-17	2012-09-05	爱尔康研究有限公司	用于眼科照明的光子晶格led
WO2011078924A1 (fr) *	2009-12-22	2011-06-30	Alcon Research, Ltd.	Refroidissement thermoélectrique pour une luminosité accrue dans une diode électroluminescente de lumière blanche
WO2011078958A1 (fr) *	2009-12-23	2011-06-30	Alcon Research, Ltd.	Illuminateur à diodes électroluminescentes (del) amélioré
US9005125B1 (en) *	2010-02-04	2015-04-14	A. Mateen Ahmed	Tonometer
US9314374B2 (en) *	2010-03-19	2016-04-19	Alcon Research, Ltd.	Stroboscopic ophthalmic illuminator
US8391943B2 (en)	2010-03-31	2013-03-05	Covidien Lp	Multi-wavelength photon density wave system using an optical switch
US8498683B2 (en)	2010-04-30	2013-07-30	Covidien LLP	Method for respiration rate and blood pressure alarm management
US8930145B2 (en)	2010-07-28	2015-01-06	Covidien Lp	Light focusing continuous wave photoacoustic spectroscopy and its applications to patient monitoring
US9380982B2 (en)	2010-07-28	2016-07-05	Covidien Lp	Adaptive alarm system and method
US8573801B2 (en)	2010-08-30	2013-11-05	Alcon Research, Ltd.	LED illuminator
US8956311B2 (en)	2010-10-13	2015-02-17	TearSciecne, Inc.	Methods for diagnosing meibomian gland dysfunction
GB201017637D0 (en) *	2010-10-20	2010-12-01	Univ Dundee	Device for monitoring intraocular pressure
US8610769B2 (en)	2011-02-28	2013-12-17	Covidien Lp	Medical monitor data collection system and method
US8715713B2 (en)	2011-04-29	2014-05-06	Allergan, Inc.	Solvent cast film sustained release latanoprost implant
CN103857996B (zh) *	2011-06-03	2016-09-14	香港科技大学	对椭圆球体壳力学性质的非破坏性测量方法
WO2013024431A1 (fr) *	2011-08-18	2013-02-21	Forus Health Pvt. Ltd.	Procédé et système de détermination de la pression intraoculaire (pio) d'un œil
WO2013040079A1 (fr)	2011-09-13	2013-03-21	Dose Medical Corporation	Capteur physiologique intra-oculaire
US20130079660A1 (en) *	2011-09-23	2013-03-28	O Chang	Method utilizing thermograph of a tear film for generating a quantified index
US20130102921A1 (en) *	2011-10-20	2013-04-25	Alain Saurer	Method and device for monitoring biomechanical properties of the eye
KR101784012B1 (ko) *	2011-11-02	2017-10-12	가톨릭대학교 산학협력단	모양체 소대강도 측정장치 및 측정방법
US9155467B1 (en) *	2011-12-13	2015-10-13	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Contoured facial mask with multiple contact probes for use with tactile tonometer
US9173564B2 (en)	2011-12-16	2015-11-03	California Institute Of Technology	System and method for sensing intraocular pressure
US9833146B2 (en)	2012-04-17	2017-12-05	Covidien Lp	Surgical system and method of use of the same
US10016132B2 (en) *	2013-03-07	2018-07-10	The Board Of Trustees Of The Leland Stanford Junior University	Implantable micro-fluidic device for monitoring of intra-ocular pressure
US9730638B2 (en)	2013-03-13	2017-08-15	Glaukos Corporation	Intraocular physiological sensor
US9289623B2 (en) *	2013-03-15	2016-03-22	Johnson & Johnson Vision Care, Inc.	Method and device for monitoring and treatment of seasonal affective disorder
US9592151B2 (en)	2013-03-15	2017-03-14	Glaukos Corporation	Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
FI20135401L (fi) *	2013-04-19	2014-10-20	Garuda Oy	Mittausmenetelmä ja mittausjärjestely sähkömagneettisten aaltojen hyödyntämiseksi
US10213140B2 (en) *	2013-05-17	2019-02-26	Johnson & Johnson Vision Care, Inc.	Ophthalmic lens with a microfluidic system
EP3278777B1 (fr) *	2013-06-25	2020-07-08	Teclens, LLC	Appareil de photothérapie de l' oeil
US9268154B2 (en) *	2013-09-17	2016-02-23	Johnson & Johnson Vision Care, Inc.	Method and apparatus for ophthalmic devices including hybrid alignment layers and shaped liquid crystal layers
WO2015054681A1 (fr)	2013-10-11	2015-04-16	Marcio Marc Abreu	Procédé et appareil pour évaluation biologique
US9642525B2 (en) *	2013-11-22	2017-05-09	Johnson & Johnson Vision Care, Inc.	Ophthalmic lens with retinal vascularization monitoring system
US9289123B2 (en) *	2013-12-16	2016-03-22	Verily Life Sciences Llc	Contact lens for measuring intraocular pressure
WO2015106180A1 (fr)	2014-01-10	2015-07-16	Marcio Marc Abreu	Dispositifs pour surveiller et appliquer un traitement au niveau d'un tunnel cérébral abreu
CA2936229A1 (fr)	2014-01-10	2015-07-16	Marcio Marc Abreu	Dispositif de mesure de sortie infrarouge du tunnel thermique du cerveau abreu
CN106163463A (zh)	2014-01-22	2016-11-23	马尔西奥·马克·阿布雷乌	配置成在abreu脑热通道提供处理的装置
FI20145205L (fi) *	2014-03-04	2015-09-05	Photono Oy	Menetelmä ja järjestelmä silmänpainemittauksiin
ES2981963T3 (es)	2014-03-07	2024-10-14	Lions Eye Institute Ltd	Método y sistema para determinar la presión intracraneal
US9538917B2 (en) *	2014-08-04	2017-01-10	Lighttouch, Llc	Applanation tonometer having cornea alignment means
WO2016145215A1 (fr)	2015-03-10	2016-09-15	Marcio Marc Abreu	Dispositifs, appareils, systèmes et procédés pour mesurer la température d'une terminaison abtt
CA2980289C (fr)	2015-03-20	2024-05-14	Glaukos Corporation	Dispositifs gonioscopiques
EP3373797B1 (fr) *	2015-11-11	2023-01-04	Microoptx Inc.	Dispositifs et méthodes de surveillance de l'humeur aqueuse
IL243686B (en)	2016-01-19	2022-05-01	Epitech Mag Ltd	Device for increasing the integrity of the eye epithelium using magnetic pulses
US20170209045A1 (en) *	2016-01-26	2017-07-27	California Institute Of Technology	System and method for intraocular pressure sensing
JP2017153875A (ja) *	2016-03-04	2017-09-07	セイコーエプソン株式会社	生体情報測定装置および生体情報測定方法
US11172560B2 (en)	2016-08-25	2021-11-09	Alcon Inc.	Ophthalmic illumination system with controlled chromaticity
EP3562378B1 (fr) *	2016-12-30	2024-08-21	I-Dynamometer GmbH	Procédé permettant de déterminer l'apparition d'un collapsus vasculaire au niveau d'un vaisseau sanguin dans ou sur l'oeil, ainsi que dispositif de retenue et système d'ophtalmo-dynamométrie
US10674906B2 (en)	2017-02-24	2020-06-09	Glaukos Corporation	Gonioscopes
USD833008S1 (en)	2017-02-27	2018-11-06	Glaukos Corporation	Gonioscope
IL253677B2 (en)	2017-07-26	2023-06-01	Epitech Mag Ltd	A magnetic device for the treatment of living tissues
CN107811629A (zh) *	2017-09-30	2018-03-20	温州医科大学附属眼视光医院	一种基于cs1237芯片、压阻传感器和单片机的压力采集信号的泪道压力检测仪
KR101964918B1 (ko) *	2017-10-17	2019-04-02	연세대학교 산학협력단	심장 전압 지도와 전위 활성화 지도에 기반한 심장 모델 생성 장치 및 방법
JP6912675B2 (ja) *	2017-12-12	2021-08-04	キャッツトノメーター，リミテッドライアビリティカンパニーＣａｔｓＴｏｎｏｍｅｔｅｒ，Ｌｌｃ	ボディに接触する光学部材により実施されるボディの内圧の光学測定の誤差の低減
WO2020010159A1 (fr) *	2018-07-02	2020-01-09	A7 Core, Inc.	Système de sécurité pour consommateurs d'entreprise
US11013407B2 (en)	2019-02-15	2021-05-25	Amo Development, Llc	Intraocular pressure measurement for an eye docked to a laser system
US11141601B2 (en)	2020-01-27	2021-10-12	Epitech Mag Ltd.	Ocular positioning device for use with magnetic treatment apparatus
KR102371645B1 (ko) *	2020-06-04	2022-03-08	고려대학교 산학협력단	상공막정맥압력 측정 장치
CN113331785B (zh) *	2021-05-12	2024-08-06	清华大学	一种无线压平式眼压监测系统
CN113827179B (zh) *	2021-09-26	2023-06-06	温州医科大学	一种眼睑压力的检测方法、装置、介质及电子设备
CN113974966B (zh) *	2021-12-09	2023-06-09	固安翌光科技有限公司	一种光疗眼罩
CN115791384B (zh) *	2023-01-09	2023-04-21	苏州熠品质量技术服务有限公司	一种基于机器视觉的球压试验压痕测量系统

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3062042A (en) *	1959-06-04	1962-11-06	George P Pilling & Son Company	Tonometer
US3934462A (en) *	1974-09-06	1976-01-27	American Hospital Supply Corporation	Automatic computing ocular tonometer system
US4192317A (en) *	1978-06-30	1980-03-11	Ical, Incorporated	Indentation tonometer
US4305399A (en) *	1978-10-31	1981-12-15	The University Of Western Australia	Miniature transducer
DE3112910C2 (de) *	1981-03-31	1983-07-21	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München	Einrichtung zum Messen des Augeninnendruckes
US5076274A (en) *	1987-02-18	1991-12-31	Canon Kabushiki Kaisha	Non-contact tonometer
US5183044A (en) *	1987-06-30	1993-02-02	Kabushiki Kaisha Topcon	Noncontact type tonometer
US4922913A (en) *	1987-11-12	1990-05-08	Waters Jr George E	Intraocular pressure sensor
US4860755A (en) *	1988-02-08	1989-08-29	Erath-Young Instrument Company, Inc.	Differential pressure applanation tonometer
US5165409A (en) *	1988-08-23	1992-11-24	Coan William M	Tonometry apparatus
US5005577A (en) *	1988-08-23	1991-04-09	Frenkel Ronald E P	Intraocular lens pressure monitoring device
US5217015A (en) *	1990-06-08	1993-06-08	Kaye David B	Pressure sensing device having transducer overlying and deforming eye
US5109852A (en) *	1990-06-08	1992-05-05	Kaye David B	Method for sensing pressure in an object
US5148807A (en) *	1990-08-28	1992-09-22	Ohio State University	Non-contact tonometer
US5295495A (en) *	1991-05-13	1994-03-22	The Australian National University	Glaucoma testing from observations of optokinetic nystagmus
US5251627A (en) *	1991-06-27	1993-10-12	Morris Donald E	Non-invasive measurement of eyeball pressure using vibration
US5179953A (en) *	1991-08-27	1993-01-19	Jermik Systems, Ltd.	Portable diurnal intraocular pressure recording system
JPH05253190A (ja) *	1991-10-10	1993-10-05	Massie Res Lab Inc	非接触式トノメーター
US5375595A (en) *	1993-03-17	1994-12-27	The Regents Of The University Of Calif.	Apparatus and method for non-contact, acoustic resonance determination of intraocular pressure
US5474066A (en) *	1994-01-31	1995-12-12	Leica Inc.	Non-contact tonometer
DE4433104C1 (de) *	1994-09-16	1996-05-02	Fraunhofer Ges Forschung	Einrichtung zur Messung mechanischer Eigenschaften von biologischem Gewebe

1996
- 1996-09-04 US US08/707,508 patent/US5830139A/en not_active Expired - Lifetime
1997
- 1997-09-04 CN CN97197637A patent/CN1229345A/zh active Pending
- 1997-09-04 EP EP97939762A patent/EP0926979A4/fr not_active Withdrawn
- 1997-09-04 JP JP10512848A patent/JP2000517231A/ja not_active Ceased
- 1997-09-04 CA CA002264193A patent/CA2264193C/fr not_active Expired - Fee Related
- 1997-09-04 IL IL12882597A patent/IL128825A/en not_active IP Right Cessation
- 1997-09-04 BR BR9711993-8A patent/BR9711993C1/pt not_active Application Discontinuation
- 1997-09-04 KR KR10-1999-7001833A patent/KR100411363B1/ko not_active IP Right Cessation
- 1997-09-04 WO PCT/US1997/015489 patent/WO1998009564A1/fr active IP Right Grant
- 1997-09-04 AU AU41778/97A patent/AU741461B2/en not_active Ceased

Also Published As

Publication number	Publication date
BR9711993C1 (pt)	2002-08-13
IL128825A0 (en)	2000-01-31
AU741461B2 (en)	2001-11-29
BR9711993A (pt)	2000-01-18
EP0926979A1 (fr)	1999-07-07
JP2000517231A (ja)	2000-12-26
CA2264193A1 (fr)	1998-03-12
AU4177897A (en)	1998-03-26
KR20000068457A (ko)	2000-11-25
CA2264193C (fr)	2008-03-25
WO1998009564A1 (fr)	1998-03-12
CN1229345A (zh)	1999-09-22
EP0926979A4 (fr)	1999-11-10
KR100411363B1 (ko)	2003-12-18
US5830139A (en)	1998-11-03

Publication	Publication Date	Title
AU761842B2 (en)	2003-06-12	Method and apparatus for signal transmission and detection using a contact device
IL128825A (en)	2004-07-25	Pressure gauge system for measuring intraocular pressure by flattening and / or a notch
AU2001284656B2 (en)	2008-07-10	Noninvasive measurements of chemical substances
AU2001284656A1 (en)	2003-03-06	Noninvasive measurements of chemical substances
AU2017201863A1 (en)	2017-04-06	Noninvasive measurements of chemical substances

Legal Events

Date	Code	Title
2004-12-15	FF	Patent granted
2005-05-17	KB	Patent renewed
2007-10-31	KB	Patent renewed
2012-04-30	MM9K	Patent not in force due to non-payment of renewal fees